Department of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53201.
Department of Biomedical Sciences, Marquette University, Milwaukee, Wisconsin 53201
J Neurosci. 2021 Jun 16;41(24):5303-5314. doi: 10.1523/JNEUROSCI.3086-20.2021. Epub 2021 Apr 20.
Relapse susceptibility in women with substance use disorders (SUDs) has been linked to the estrogen, 17β-estradiol (E2). Our previous findings in female rats suggest that the influence of E2 on cocaine seeking can be localized to the prelimbic prefrontal cortex (PrL-PFC). Here, we investigated the receptor mechanisms through which E2 regulates the reinstatement of extinguished cocaine seeking. Sexually mature female rats underwent intravenous cocaine self-administration (0.5 mg/inf; 14 × 2 h daily) and extinction, and then were ovariectomized before reinstatement testing. E2 (10 µg/kg, i.p.) alone did not reinstate cocaine seeking, but it potentiated reinstatement when combined with an otherwise subthreshold priming dose of cocaine. A similar effect was observed following intra-PrL-PFC microinfusions of E2 and by systemic or intra-PrL-PFC administration of the estrogen receptor (ER)β agonist, DPN, but not agonists at ERα or the G-protein-coupled ER1 (GPER1). By contrast, E2-potentiated reinstatement was prevented by intra-PrL-PFC microinfusions of the ERβ antagonist, MPP, or the GPER1 antagonist, G15, but not an ERα antagonist. Whole-cell recordings in PrL-PFC layer (L)5/6 pyramidal neurons revealed that E2 decreases the frequency, but not amplitude, of GABA-dependent miniature IPSCs (mIPSC). As was the case with E2-potentiated reinstatement, E2 reductions in mIPSC frequency were prevented by ERβ and GPER1, but not ERα, antagonists and mimicked by ERβ, but not GPER1, agonists. Altogether, the findings suggest that E2 activates ERβ and GPER1 in the PrL-PFC to attenuate the GABA-mediated constraint of key outputs that mediate cocaine seeking.
在有物质使用障碍(SUD)的女性中,复发易感性与雌激素 17β-雌二醇(E2)有关。我们之前在雌性大鼠中的发现表明,E2 对可卡因寻求的影响可以定位到额前皮质(PrL-PFC)。在这里,我们研究了 E2 调节已灭绝可卡因寻求恢复的受体机制。性成熟的雌性大鼠接受静脉内可卡因自我给药(0.5mg/inf;每天 14×2 小时)和消退,然后在恢复测试前进行卵巢切除术。E2(10μg/kg,ip)本身不会重新引发可卡因寻求,但与可卡因的亚阈值引发剂量联合使用时会增强可卡因的重新寻求。在 PrL-PFC 内微输注 E2 以及全身或 PrL-PFC 内给予雌激素受体(ER)β激动剂 DPN 时观察到类似的效果,但 ERα 或 G 蛋白偶联受体 1(GPER1)的激动剂则没有。相比之下,PrL-PFC 内微输注 ERβ 拮抗剂 MPP 或 GPER1 拮抗剂 G15 可预防 E2 增强的重新寻求,但 ERα 拮抗剂则不能。在 PrL-PFC 层(L)5/6 锥体神经元中的全细胞膜片钳记录显示,E2 降低 GABA 依赖性微小 IPSC(mIPSC)的频率,但不改变其幅度。与 E2 增强的恢复一样,E2 降低 mIPSC 频率可被 ERβ 和 GPER1 拮抗剂预防,而被 ERα 拮抗剂模拟,并可被 ERβ 但不是 GPER1 激动剂模拟。总之,这些发现表明,E2 在 PrL-PFC 中激活 ERβ 和 GPER1,以减轻介导可卡因寻求的关键输出的 GABA 介导的约束。